Drug hope for people with common heart thickening disease. A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A new drug offers hope for people with hypertrophic cardiomyopathy, the world's most common inherited heart disease. The TEMPEST trial, led by University of Manchester researchers, tested the drug—called trientine—in 154 adults with the condition in a yearlong, placebo-controlled study.
- Ponto de atenção: drug.
- Ponto de atenção: hope.
- Ponto de atenção: people.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
